Antithymocyte globulin or interleukin 2 receptor antibody for immunosuppressive induction therapy after orthotopic liver transplantation: a follow-up study

Transplant Proc. 1993 Aug;25(4):2701.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Antilymphocyte Serum / adverse effects
  • Antilymphocyte Serum / therapeutic use*
  • Female
  • Follow-Up Studies
  • Graft Rejection / prevention & control
  • Humans
  • Liver Transplantation / immunology*
  • Liver Transplantation / mortality
  • Male
  • Receptors, Interleukin-2 / immunology
  • Survival Analysis
  • Time Factors

Substances

  • Antibodies, Monoclonal
  • Antilymphocyte Serum
  • Receptors, Interleukin-2
  • inolimomab